Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3441-3443

  McCalla, Carlo ^a   Smyth, Davida S ^a   Robinson, D Ashley ^a   Steenbergen, Judith ^b   Luperchio, Steven A ^b   Moise, Pamela A ^b   Fowler Jr , Vance G ^c   Sakoulas, George ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b CUBIST PHARMACEUTICALS INC   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GENTAMICIN; HEMOLYSIN; VANCOMYCIN;

ACCESSORY GENE REGULATOR; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATE; GENE FUNCTION; GENOTYPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; DAPTOMYCIN; ENDOCARDITIS, BACTERIAL; GENOTYPE; HEMOLYSIN PROTEINS; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 50949087909     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00357-08     Document Type: Article

References (16)

1. Fowler, V. G., Jr., G. Sakoulas, L. M. McIntyre, V. G. Meka, R. D. Arbeit, C. H. Cabell, M. E. Stryjewski, G. M Eliopoulos, L. B. Reller, G. R. Corey, T. Jones, N. Lucindo, M. R. Yeaman, and A. S. Bayer. 2004. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190:1140-1149.
2. Fowler, V. G., Jr., H. W. Boucher, G. R. Corey, E. Abrutynet, A. W. Karchmer, M. E. Rupp, D. P. Levine, H. F. Chambers, F. P. Tally, G. A. Vigliani, C. H. Cabell, A. S. Link, I. DeMeyer, S. G. Filler, M. Zervos, P. Cook, J. Parsonnet, J. M. Bernstein, C. S. Price, G. N. Forrest, G. Fätkenheuer, M. Gareca, S. J. Rehm, H. R. Brodt, A. Tice, and S. E. Cosgrove for the S. aureus Endocarditis and Bacteremia Study Group. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653-665.
3. Gilot, P., G. Lina, T. Cochard, and B. Poutrel. 2002. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis. J. Clin. Microbiol. 40:4060-4067.
4. Harmsen, D., H. Claus, W. Witte, J. Rothganger, H. Claus, D. Turnwald, and U. Vogel. 2003. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41:5442-5448.
5. Hidayat, L. K., D. I. Hsu, R. Quist, K. A. Shriner, and A. Wong-Beringer. 2006. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166:2138-2144.
6. Ito, T., Y. Katayama, K. Asada, N. Mori, K. Tsutsumimoto, C. Tiensasitorn, and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1323-1336.
7. Koreen, L., S. V. Ramaswamy, E. A. Graviss, S. Naidich, J. M. Musser, and B. N. Kreiswirth. 2004. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J. Clin. Microbiol. 42:792-799.
8. Maree, C. L., R. S. Daum, S. Boyle-Vavra, K. Matayoshi, and L. G. Miller. 2007. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg. Infect. Dis. 13:236-242.
9. Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
10. Naimi, T. S., K. H. LeDell, and K. Como-Sabetti. 2003. Comparison of community- and health-care associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.
11. Robinson, D. A., and M. C. Enright. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934.
12. Sakoulas, G., G. M. Eliopoulos, R. C. Moellering, Jr., C. Wennersten, L. Venkataraman, R. P. Novick, and H. S. Gold. 2002. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 46:1492-1502.
13. Sakoulas, G., P. A. Moise, J. J. Schentag, A. Forrest, R. C. Moellering, Jr., and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
14. Sakoulas, G. 2006. The accessory gene regulator (agr) in methicillin-resistant Staphylococcus aureus: role in virulence and reduced susceptibility to glycopeptide antibiotics. Drug Discov. Today 3:287-294.
15. Soriano, A., F. Marco, J. A. Martinez, E. Pisos, M. Almela, V. P. Dimova, D. Alamo, M. Ortega, J. Lopez, and J. Mensa. 12 December 2007. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. doi: 10.1086/524667. [Epub ahead of print.]
16. Tsuji, B. T., M. J. Rybak, C. M. Cheung, M. Amjad, and G. W. Kaatz. 2007. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn. Microbiol. Infect. Dis. 58:41-47.